Drvota V, Vesterqvist O, Gréen K
Department of Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden.
Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:153-6.
Most NSAIDs seem to have inhibitory effects on the in vivo synthesis of both TxA2 and PGI2. However there are large differences in the duration of the inhibitory effects as shown in the table below. Aspirin, indomethacin, naproxen and piroxicam inhibit the second wave of platelet aggregation. This effect on platelet aggregation persists as long as each drug causes inhibition of TxA2 synthesis. Thus, inhibition of TxA2 synthesis is likely to be the reason for the effect of NSAIDs on platelet function. The lack of effect of paracetamol on TxA2 synthesis together with the lack of effect on platelet aggregation by paracetamol are in further support of this. [table: see text]
大多数非甾体抗炎药似乎对血栓素A2(TxA2)和前列环素(PGI2)的体内合成均有抑制作用。然而,如下表所示,其抑制作用的持续时间存在很大差异。阿司匹林、吲哚美辛、萘普生和吡罗昔康可抑制血小板聚集的第二波。只要每种药物抑制TxA2的合成,这种对血小板聚集的作用就会持续。因此,抑制TxA2的合成可能是非甾体抗炎药对血小板功能产生作用的原因。对乙酰氨基酚对TxA2合成缺乏作用以及对血小板聚集缺乏作用进一步支持了这一点。[表:见正文]